{"name":"Aduro Biotech, Inc.","slug":"aduro-biotech-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"CRS-207","genericName":"CRS-207","slug":"crs-207","indication":"Mesothelioma","status":"phase_2"}]}],"pipeline":[{"name":"CRS-207","genericName":"CRS-207","slug":"crs-207","phase":"phase_2","mechanism":"CRS-207 is a live, attenuated Listeria monocytogenes vaccine that stimulates an immune response against mesothelin.","indications":["Mesothelioma"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNNmhqZ0ZlQ2kxc29nOEJDenBRUXdnMUFia0dNbHF0dFJsWUVrczM2SDNSV0dCdURGWXVNQVRfVzhiNkJDV0IwQjRGMDFuXy11dVFtMmJEWVJJV1JlVVJOTXFRRUg5X04zRDAxTmZBV09PVmVNcHhlaUtYSHE2SXBWaTFmVDhmcnZD?oc=5","date":"2025-11-14","type":"trial","source":"Market Data Forecast","summary":"Pancreatic Cancer Market Size, Growth Report & Trends, 2033 - Market Data Forecast","headline":"Pancreatic Cancer Market Size, Growth Report & Trends, 2033","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTFAta0U2N3FIN0k4em5rcHdpNGdaS3BjSWRVVHZqTWt5ZExDTEFRWUlXbS1Cd29CbFRHMVlqS2xSaWttWjdiT19idlB1elRMYWxJMVhfRl9kT0I1dEVJU3NmcjNaY3VKVHhDczFmeWFYSE1Ianh2bnJuSVdXRQ?oc=5","date":"2025-01-23","type":"trial","source":"acsjournals.onlinelibrary.wiley.com","summary":"A phase 2 basket study of talabostat, a small-molecule inhibitor of dipeptidyl peptidases, administered in combination with pembrolizumab in patients with advanced solid cancers - acsjournals.onlineli","headline":"A phase 2 basket study of talabostat, a small-molecule inhibitor of dipeptidyl peptidases, administered in combination w","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxObGVSLVNaVkZ2eGlfUVl1RFcwVlBnRWtLMHJES1RtLS02RHd6UFYzOU5xbUxYY0NiRm8ybVg5OVdRWk5pZUt0VUhSd3RPdkFCV3JqaXlSMFdBSzA4aWdXaTZOcWEzLUY4NW16OEd6Y0FCREZNQjIzVDRQY2dGalNPYWZZZnh2eU9YbXBtOVEzTmtsakNJSW9Xc0hiMnZwbktZbTNV?oc=5","date":"2023-06-12","type":"deal","source":"GeekWire","summary":"Novartis to buy Seattle biotech firm Chinook Therapeutics in $3.2B deal - GeekWire","headline":"Novartis to buy Seattle biotech firm Chinook Therapeutics in $3.2B deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiW0FVX3lxTE50NE11N2lRSHhHN1VQb1dnLVlmZjBQTGU0dGxwU0tJSG9hVUxNYXJVZ0I1aHBCdVlVbHNKVVdpQzlrSVN5cmxLX3pRQlJDQnlGQXVkeWE4eEcyTVk?oc=5","date":"2022-12-20","type":"pipeline","source":"EurekAlert!","summary":"3D-patient tumor avatars: Maximizing their potential for next-generation precision oncology - EurekAlert!","headline":"3D-patient tumor avatars: Maximizing their potential for next-generation precision oncology - EurekAlert!","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxPSHBib2dQWnJDR2htQm5XU3diZ3dUX0hpYmNYRXV2UWNlX0R6MVFRNmZCeFdKZkJkLUx2czRsUk03andwNzVWYnlweGpXYVZ4VF9pakFOcUVCTGxYdTBuQ2t4T3lqRlVYZ25zZEtGYmRkeHpRX3dhblViRGtrbV9JWkFsNUZ2cTZHNFhfUXdYYUFwc2VOdzJJd2phZlcxRUUxazEzME14MG4yVVB1eGRDaDFsMmJoZ2p2V0NNblo0bGFSaWpkX19HVTdMRlQxMXI3V29TaE9lajZHcmQxdkRmUnBkQQ?oc=5","date":"2020-10-01","type":"regulatory","source":"GlobeNewswire","summary":"Aduro Biotech Stockholders Approve Merger Agreement with Chinook Therapeutics - GlobeNewswire","headline":"Aduro Biotech Stockholders Approve Merger Agreement with Chinook Therapeutics","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiZEFVX3lxTFBGRDk0NVBiR0FqWjlOcVpwbC1pR2dvRWpYSW5PbG95cndkTEVoemcwcTJxSWJZemk4ZnVYOFU1SVpCSk45WmJ1UUYtVGQ1WnBlOERuMVhxbFhaQTdfenMxSzlQUWM?oc=5","date":"2020-07-24","type":"pipeline","source":"labiotech.eu","summary":"Swiss Company Raises €23M to Smash Cancer with Bacteria - labiotech.eu","headline":"Swiss Company Raises €23M to Smash Cancer with Bacteria","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxPajZWazdLX0JkZE01T0R0Sk4yTkktMm9Tc0hNcXlFekV3MnFSOUJWRjhNaG5MYllJNlQtQXZsdDhOdk1ueDBfUEt2RUhZVFVldVo5X3hhN0RxSXZyanJfZFNncW1DRnhndjdldWRPcW1YMlZsUzRhOXo4LWh5M2xyUXl3SzNFYlNaTi1hUGppRDRpYzhGdHlMQ05wQ0c1WHF5M0IwYklETDZfajhERXhzQXhfVXFCS09lQmtxNzVFc3BJeFBZOFZ3LWpra2dtY2dsQV9kcDBJRjRYTnBjMU10cg?oc=5","date":"2020-06-02","type":"deal","source":"GlobeNewswire","summary":"Aduro Biotech and Chinook Therapeutics Announce Definitive Merger Agreement - GlobeNewswire","headline":"Aduro Biotech and Chinook Therapeutics Announce Definitive Merger Agreement","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxNMkJDbUVsLXRpZXpXUUt4VUZOYk9fb1ZJcS1SdjdnOUxhbmxJbTctSWp5aHB1eUFPVklXNm9uRWhZdE5RQkRCR1NxUUh4S3l6ejFnU1E0bzhUTEdMZVRzcjV1WXQ0V3E3SzVaby16akt0akRBTUxrMW94YWpYY0RkdU1lUHl2Qm5yMUtuYUxIX0hoOW9hV2hvS0d3UQ?oc=5","date":"2020-04-01","type":"pipeline","source":"Bloomberg Law News","summary":"A Look At What Some of Big Pharma’s Top Lawyers Earned in 2019 - Bloomberg Law News","headline":"A Look At What Some of Big Pharma’s Top Lawyers Earned in 2019","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxONHZYakdSRDl0U2VMX21TSEZZTkp5c3F0bU1fb21JU2ZUV0E5TzRiWnlfMEplaGd3U1YxZTIxSmluX3VWdXlnQjZmOFR3R0VTUlh6ay02T1Y5aWlmazZZZmVIVVhyMU54WmtteDg0TWdYT0V0V01CbEthQm1KRDZRWmRWSGFxMnVhVjNEZFVoRjNtQQ?oc=5","date":"2019-07-15","type":"deal","source":"Fierce Biotech","summary":"AbbVie jumps into STING cancer work with Mavupharma buy - Fierce Biotech","headline":"AbbVie jumps into STING cancer work with Mavupharma buy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxPdF80a21zZHVwMEhQMTM1aUxDOUl6WXdMdkpPU0J5aFdoMURZVUw1UnFhSUFhdFgzUjE5aUZ3d2IycnBJODM0WlEyM3c4VzRibURsaW1hM1FyNEsyMHNrUW1xTW93OGpoc3k5MUNOcnlwZy1SbzZ4aUYwMWNwSUNWZXByN1hFOTBLdWRmMHhmY2poM1RoaWlEZ1FzMlBBRTFGcGlmQnZCOC1DOVNvcEFoQldFbEJOY20tLTM0R0ZB?oc=5","date":"2018-12-18","type":"deal","source":"Eli Lilly","summary":"Lilly and Aduro Biotech Announce Research Collaboration and License Agreement to Develop Novel Immunotherapies - Eli Lilly","headline":"Lilly and Aduro Biotech Announce Research Collaboration and License Agreement to Develop Novel Immunotherapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxNYW5kZG84RmcwS0V3NHFWQW5hOVBuQ2NkaHREeUFtVWxNRkJST24ySlVidEpJYk5DaU9GR1JTN2oxZkRQdHFoVi1SLWVfdnRERnVPVkxLS3k2LW04ZHBobGRaZzZ0UDZMM2JCZDhlU0dBZnhxT1ZiYzFpcnZ6blB3SVYxMjJZcmt1U3FNbGRJUW9lWUd6YXFUdk5B?oc=5","date":"2017-12-13","type":"pipeline","source":"BioPharma Dive","summary":"Aduro’s troubled CRS-207 reaches the end of the line - BioPharma Dive","headline":"Aduro’s troubled CRS-207 reaches the end of the line","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxPdW5HN1ZXNmo5MFVtMkljc2ozZzNxZ0xNUlFJR1JTMjNaYUdxYWQycllhQ19odVplSWJzN2FBVzJQeG9iYmZjdk8zajdKVjE4U2h0TmFHQWNBZlNvWlF2NkhRRlpXQ3FvdEVXeDh4bFJwT3Y4dndqdGRLSnVERUZINEszeS03QWxaYUNkb0hLU1NMSXdWNzRxZWJraU5wVklJZS1LdnkwcFV1NE5tQnVGeA?oc=5","date":"2016-05-16","type":"trial","source":"BioPharma Dive","summary":"Aduro’s pancreatic immunotherapy fails phase 2, sending stock tumbling - BioPharma Dive","headline":"Aduro’s pancreatic immunotherapy fails phase 2, sending stock tumbling","sentiment":"negative"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}